US Patent 6991797 M. tuberculosis antigens
Patent 6991797 was granted and assigned to Statens Serum Institut on January, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 11 Nov, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+378 characters)
Article
Patent abstract
The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptides.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Peter Andersen0
Rikke Louise Vinther Skjøt0
Date of Patent
January 31, 2006
0Patent Application Number
098049800
Date Filed
March 13, 2001
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6991797 M. tuberculosis antigens
Find more entities like US Patent 6991797 M. tuberculosis antigens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
